Back to top

View the PFP Archive

Stocks closed lower yesterday after spending a good portion of the day in the green.
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research
  

Stocks Closed Lower Yesterday, All Eyes On This Morning's PCE Inflation Report

Stocks closed lower yesterday after spending a good portion of the day in the green.

Likely position squaring ahead of this morning's Personal Consumption Expenditures (PCE) index, which is the Fed's preferred inflation gauge, weighed on shares late.

The PCE headline numbers are expected to show inflation up 0.2% m/m vs. last month's 0.1% pace, while the y/y rate is expected to tick down to 2.1% vs. last month's 2.2%. The core rate (ex-food & energy) is expected to be up 0.3% m/m vs. last month's 0.1%. The y/y rate is expected to tick down to 2.6% vs. last month's 2.7%.

Yesterday's advance estimate for Q3 GDP, which came in at 2.8%, was slightly below the prior rate of 3.0% and views for the same, but the PCE portion (also part of the GDP report) for Q3 (annual rate) came in at 3.7%, which was higher than the previous 2.8% and consensus for 3.0%. Granted, that's in the rearview mirror. But it might have spooked some. Especially after the CEO of BlackRock, Larry Fink, on Tuesday said he does not believe the Fed will cut rates as much as some are expecting, contending that inflation is embedded more now than we've ever seen in the world. So all eyes will be on this morning's PCE report.

Early morning earnings by Eli Lilly didn't help as they posted a negative EPS surprise of -22.4%, and a negative sales surprise of -4.92%. They were down -6.28% on the day. AbbVie, on the other hand, posted a positive EPS surprise of 2.74%, and a positive sales surprise of 1.29%. They were up 6.36% on the day. But that did not translate to broader support for the market.

After close we heard from Microsoft, and they posted a positive EPS surprise of 7.14%, and a positive sales surprise of 1.82%. That equated to a quarterly EPS growth rate of 10.4% vs. this time last year, and a sales growth of 16.0%. They were up 0.13% in the regular session before earnings, and up roughly 0.60% in after-hours trade following earnings.

We also heard from Meta, which posted a positive EPS surprise of 16.2%, and a positive sales surprise of 0.95%. That showed a quarterly EPS growth rate of 16.2% vs. this time last year, and a sales growth of 18.9%. They were off -0.25% in the regular session before earnings, and down roughly -1.75% in after-hours trade following earnings.

Today we'll get another 261 companies on deck to report, with Uber and Bristol Myers going before the open, and Apple and Amazon posting after the close.

In other news yesterday, MBA Mortgage Applications showed the Composite down -0.1% w/w with Purchases up 5.0%, but Refi's down -6.3%.

Pending Home Sales were up 7.4% m/m vs. last month's 0.6% and estimates for 1.0%. The Index itself came in at 75.8 vs. last month's 70.6.

We also got the ADP Employment report which showed private payrolls at 233,000 vs. last month's 159,000 and the consensus for just 115,000.

That report got a lot of attention, given the huge upside surprise. And with the Employment Situation report by the Bureau of Labor Statistics (BLS) coming out tomorrow (which will be the last labor report the Fed gets before their FOMC meeting next week on November 6-7), that too could have an impact on the Fed's decision on rates.

So, after today's PCE inflation report, everyone will shift their focus to tomorrow's BLS Employment report.

See you tomorrow,

Kevin Matras

Executive Vice President, Zacks Investment Research

Sponsor

5 Stocks Set to Double: Deadline Approaching

There's still time to get in on our just-released 5 Stocks Set to Double Special Report. Each pick is the single favorite of a Zacks expert with the best chance to crush the market and gain +100% and more in the months ahead:

Stock #1: Disruptive Fintech Partnering with Retail Giants

Stock #2: Junior Miner Surging on Record-High Gold Prices

Stock #3: Dominant Internet Stock Gained +185% – Now Set to Double Again

Stock #4: Healthcare Company at the Forefront of 2 Megatrends

Stock #5: Cutting-Edge Biotech Developing Next-Gen Obesity Drug

We can't guarantee future performance, but previous editions have racked up gains of +143%, +498%, and even +673%.

Deadline to download the new report is midnight Sunday, October 31.

See Stocks Now »

Most Popular Articles from Zacks.com

Image: Bigstock

Tech Flexes Earnings Power: A Closer Look

The market loved the Tesla report last week and had a similar reaction to Alphabet's release. Read More »

Image: Bigstock

Is Reddit's (RDDT) Stock at an Inflection Point After Strong Q3 Results?

Soaring to new highs, RDDT has spiked more than +30% after crushing its third-quarter expectations. Read More »

Image: Bigstock

Is Royal Caribbean Stock the King of the Ocean?

While other cruise stocks have struggled, Royal Caribbean shares continue to steam ahead. Read More »

Image: Bigstock

3 Stocks to Buy Following Robust Quarterly Results

PFF, PM and THC have stolen the spotlight in the Q3 reporting cycle, with each raising guidance. Read More »

Image: Bigstock

GameStop Trading at a Discount: How to Approach the Meme Stock?

The original "meme stock", that ignited a social media-fueled trading frenzy, is now sitting at a significant discount. Read More »

Sponsor

Increase Investment Returns with Free Zacks' Portfolio Tracker

Catch breaking news on your stocks and funds at a glance, including timely recommendation changes ... Zacks Ranks ... Industry Ranks ... earnings announcements ... earnings estimate revisions ... and more. And now you can screen for new stocks to improve portfolio performance.

Click for Free Tracker & Screener »

Image: Bigstock

Bull of the Day: Boot Barn (BOOT)

As the dust settles, could this stock be the one to lasso in big gains? Read More »

New Zacks Strong Buys for October 31st

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »

 

Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.